C3i, is a full-service CDMO offering in-house services from, process development to commercial GMP manufacturing, Qc analytical development of tests and testing, biomarker development, immune monitoring, and CRO. Operating in Montreal, Canada, C3i offers an integrated structure for the development, translation and commercialisation of these ground breaking therapies. Offer our clients a "one-stop-shop" solution for the development, translation, and commercialization of their products: Our services - GMP Manufacturing Unit for Cell and Gene therapies - in-house testing Qc, Biomarker-Diagnostic and test development - Clinical Research offering KOLs, protocol development, and Key patient access - Investment & support for innovative companies